Analyst Corner – Torrent Pharma: Maintain ‘neutral’; roll TP to Rs 2,800

The current valuation adequately factors in an upside in the Branded Generics segment. We maintain our ‘neutral‘ rating.

from The Financial Express https://ift.tt/3j5t4ol
https://ift.tt/eA8V8J Motilal Oswal